Skip to main content
. 2009 Feb 26;6:4. doi: 10.1186/1477-7517-6-4

Table 1.

Opioid users under treatment with sublingual buprenorphine in the northeastern states of Manipur and Nagaland, India

Name of NGO Target Waitlist Currently under treatment Primary drug of use HIV testing and ART treatment

Total Females (%) Heroin or brown sugar Dextropropoxyphene Combination HIV status known Ref for VCCT Ref for ART
Manipur

Care Foundation (Imphal) 100 51 91 3 (3.3%) 80 (87.9%) 11 (12.1%) 0 (0%) 49 (53.8%) 56 (61.5%) 7 (7.7%)

Care Foundation (Nambol) 75 0 60 1 (1.7%) 31(51.7%) 25 (41.7%) 4 (6.7%) 9 (15%) 35 (58.3%) 0 (0%)

DPU 75 25 94 3 (3.2%) 63 (67%) 0 (0%) 31 (33%) 24 (25.5%) 24 (25.5%) 2 (2.1%)

MNP+ 100 150 102 0 (0%) 80 (78.4%) 7 (68.6%) 15 (14.7%) 65 (63.7%) 32 (31.4%) 9 (8.8%)

Ramungo Library 75 0 77 0 (0%) 4 (5.2%) 4 (5.2%) 69 (89.6%) 6 (7.8%) 21(27.3%) 2 (2.6%)

SASO (East) 100 30 100 0 (0%) 61 (61%) 4 (4%) 35 (35%) 32 (32%) 15 (15%) 1 (1%)

SASO (West) 100 27 100 2 (2%) 72 (72%) 10 (10%) 18 (18%) 26 (26%) 19 (19%) 6 (6%)

Sahara 100 0 110 7 (6.4%) 101(91.8%) 4 (3.7%) 5 (4.5%) 44 (40%) 35 (31.8%) 23 ((20.9%)

SHALOM 100 0 110 7 (6.4%) 68 (61.8%) 12 (10.9%) 30 (27.3%) 2 (1.8%) 23 (20.9%) 9 (8.2%)

Manipur Total 825 283 844 23 (2.7%) 560 (66.4%) 77 (9.1%) 207 (24.5%) 257 (30.5%) 260 (30.8%) 59 (7%)

Nagaland

Bethesda (IDU) 100 168 114 0 (0%) 0 (0%) 1 (0.9%) 113 (99.1%) 3 (2.6%) 15 (13.2%) 0 (0%)

Bethesda (IDUSW) 100 0 106 79 (73.1%) 16 (15.1%) 12 (11.3%) 78 (73.6%) 13 (12.3%) 12 (11.3%) 0 (0%)

Bethesda- Pfutsero 75 0 60 0 (0%) 0 (0%) 54 (90%) 6 (10%) 0 (0%) 0 (0%) 0 (0%)

Kripa Foundation 100 0 124 0 (0%) 31(25%) 93 (75%) 0 (0%) 0 (0%) 11 (8.9%) 0 (0%)

Nagaland Total 375 168 404 79 (19.6%) 47 (11.6%) 160 (39.6%) 197 (48.8%) 16 (4%) 38 (9.4%) 0 (0%)

Grand Total 1200 451 1248 102 (8.2%) 607 (48.6%) 237 (19%) 404 (32.4%) 273 (21.9%) 298 (23.9%) 59 (4.7%)